Article Sidebar

PDF (Tiếng Việt)
Published: 2023-02-28
Abstract Views: 173
Views PDF (Tiếng Việt): 283
DOI: https://doi.org/10.52852/tcncyh.v163i2.1445
Issue
Vol. 163 No. 2 (2023)
Section
Các bài báo
How to Cite
Hiếu, N. L. ., Nguyên, N. M., Thành, N. T., Phương, V. H., Hoa, K. T., Nghị, P. H., Liêm, T. N., & Hải, H. B. (2023). 27. Application of low - level Laser therapy and Led in supporting the treatment of moderate Covid-19 patients. Journal of Medical Research, 163(2), 236-243. https://doi.org/10.52852/tcncyh.v163i2.1445

27. Application of low - level Laser therapy and Led in supporting the treatment of moderate Covid-19 patients

Nguyen Lan Hieu, Nguyen Minh Nguyen , Nguyen Tat Thanh, Vu Hoang Phuong, Kieu Thi Hoa, Pham Huuu Nghi, Tran Ngoc Liem, Hoang Bui Hai

Main Article Content

Abstract

The objective was to evaluate the application of low-level laser therapy and LED in supporting the treatment of moderate COVID patients.eThis is a cross-sectional descriptive study, where data were collected prospectively at the Hospital for the treatment of COVID-19 patients from October 2021 to October 2022. The patients received standard treatment combined with Laser-LED therapy daily and were monitored until discharged from the hospital. The study was conducted on 28 patients, the patients mean age was 59.6 ± 15.0, 42.9% was not vaccinateds and the rate of comorbidities disease accounted for 64.3%. On admission, 57.1% had respiratory failure requiring oxygen support with an average lung injury of 5.7 ± 2.8 and 25% met the criteria for a cytokine storm. The duration of laser-LED therapy was 8 days, the mean hospital stay was 9 days, and there was no severe transfe nor death. All moderate COVID-19 patients received standard treatment combined with laser-LED therapy without severe transformation, recovered without any adverse effects recorded.

Article Details

Keywords

Moderate COVID-19 patients, Low-level laser therapy, LED, Hanoi Medical University Hospital, COVID-19 Hospital

References

1. Parasher A. (2021). COVID-19. Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 2021; 97: 312–320.
2. Sergey M., 1 Evgeniy A., et al (2021). Low-Level Laser Therapy in Prevention of the Development of Endothelial Dysfunction and Clinical Experience of Treatment and Rehabilitation of COVID-19 Patients. Rehabilitation Research and Practice, Volume 2021.
3. Lotfi M, et al (2020). COVID-19. Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta 508 (2020) 254–266.
4. ChunMiao Bao, et al (2021). A triple combination of treatments on moderate COVID-19. Published online 2021 May 14. doi: 10.1515/med-2021-0279.
5. Nguyễn Thùy Linh, Hoàng Thị Hằng và Cộng Sự (2021). Tình trạng dinh dưỡng và đặc điểm nuôi dưỡng qua ống thông dạ dày ở người bệnh hồi sức tích cực tại bệnh viện điều trị người bệnh Covid-19. Tạp Chí Nghiên Cứu y Học.
6. Reinaldo B. B., et al (2021). Pharmacological treatment of patients with Mild to Moderate COVID-19: A Comprehensive Review. Int J Environ Res Public Health.
7. Wu Z., McGoogan J.M. (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA.2020; 323: 1239–1242.doi: 10.1001/jama.2020.2648.
8. Stefano Cappanera et al (2021) When does the cytokine storm begin in covid-19 patients? a quick score to recognize It. J Clin Med. 2021 Jan 15; 10(2): 297. doi: 10.3390/jcm10020297.
9. Bộ Y Tế (2021). Hướng dẫn chẩn đoán và điều trị COVID-19 (cập nhật lần thứ 7). số 4689/QĐ-BYT.
10. WHO (2022). Therapeutics and COVID-19. Living guideline. 14072022.